Anne Wojcicki’s DNA testing company has rebounded from its 2013 FDA slapdown by concentrating on genealogy and slowly reintroducing health reports. It’s also working with researchers to help in drug discovery and development.
The genealogy giant, which focuses on connecting customers with lost relatives, claims some 1.5 million genomes in its database, thanks to its AncestryDNA testing kit.
Like Helix, this new service promises to bring down the cost of sequencing. Users will be able to peruse genetic insights online via a data-visualization tool.
Founded by veterans of Google and Twitter, Color looks for common genes associated with a higher risk of hereditary cancers for a flat rate of $224.